We want to be your R&D business partner; leave the R&D efforts (risks, costs, and pressure) with us and use your energy for your brand and growth.
We have strong expertise in formulation; we create and test formulas every day in our labs.
We have a strong network in Brazil, which is one of the world's hottest and most developed cost-effective hubs for cosmetics R&D.
Together in our network, we can manage projects from A to Z: perform all tests (including stability, microbiology, human cell in vitro assays, clinicals, consumer panels, and more), RM prospection and selection, toxicology and safety assessments, package development, regulatory services, supply chain design, quality documentation and systems, tech transfer, IP transfer, scientific publication, legal, after-sales, and all the R&D steps.
Talk to us, and we can explain why we are the best choice to be your R&D business partner: info@oformulista.com.br
Company Details
- Employees
- 1
- Founded
- -
- Address
- Curitiba, Br
- Industry
- Research Services
- NAICS
-
Scientific Research and Development ServicesResearch and Development in the Physical, Engineering, and Life SciencesResearch and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Keywords
- cosmetic, R&D, formulation, quality, projects, skincare, suncare, Q&Q creation, risks management, cosmetics labs.
- HQ
- Curitiba
O Formulista Questions
O Formulista's LinkedIn profile is https://br.linkedin.com/company/o-formulista
O Formulista has
1 employees.
View email and phone details for 1
employees at O Formulista.
O Formulista's industry is
Research Services
O Formulista's top competitors are
Sallve,
Kboock Inovação Cosmética,
Skelt Beauty Brands,
Go.lab Consultoria Em Cosméticos,
Oriflame Cosmetics,
Allchemiq Instituto De Ciências Cosméticas,
Galderma,
Evoluir Cosmética,
Abefarma - Associação Brasileira De Educação Farmacêutica, Nutracêutica E Cosméticos,
Grupo Boticário.
O Formulista's categories are Research Services
O Formulista's founding year is 2022
